Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need.
Follow us on Twitter @Penumbrainc @PenVascular @PenNeuro
Follow us on LinkedIn
Visit our website at www.penumbrainc.com
Thrombus Management in ACS: Key Results of The CHEETAH Study
By
Penumbra, Inc.
FEATURING
Santhosh Jay Mathews
By
Penumbra, Inc.
FEATURING
Santhosh Jay Mathews
Presented at TCT 2021, the CHEETAH trial marks the first study looking at continuous power aspiration for high thrombus burden in the coronaries. National Principal investigator Dr. Jay Mathews from Manatee Memorial shares the key results from the CHEETAH Trial and discusses the clinical impact of this technology.
Login to view comments.
Click here to Login
